Indeed, exfoliated ascitic and metastatic ovarian cancer cells had increased Zeb2- and Akt2-expression compared to in situ lesions [56] and weaker E-cadherin expression compared to the primary tumor [57]. The gene discussed is CDH1; the disease is neoplasm.